Plan better and budget smarter with the Vizient Drug Price Forecast

We provide our members with market-leading solutions like the Drug Price Forecast to help manage drug price increases and with insights on new innovations and initiatives that advance the U.S. market towards high-quality, value-based care.

Download the highlights and summary now

Vizient Pharmacy Program participants

Log in to access the full January 2019 Drug Price Forecast.

How can the Drug Price Forecast help you?

The Vizient® Drug Price Forecast projects prescription drug price trends for 2019-2020 for key drugs and drug classes, based on our industry-leading data and analytics, and offers expert insights on topics critical to pharmacy practice.

"The coming year is set to be a big one, with the approval of more biosimilars for high-cost originator drugs, increased regulatory requirements, greater scrutiny of drug costs and continued development of personalized therapies. The Vizient Drug Price Forecast delivers the insights health care executives and providers need to track how changes like these affect both expenditures and outcomes."

Steven Lucio, PharmD, BCPS
Vice President, Pharmacy Solutions
Steven Lucio

Vizient Drug Price Forecast

The detailed projections of prescription drug price trends provided in the Vizient Drug Price Forecast are based on the comprehensive data of the nation’s largest group purchasing organization and cover the drugs and drug classes most critical to our members, such as oncology drugs, specialty pharmaceuticals, and pediatric medications.

The January 2019 forecast is intended to help Vizient Pharmacy Program participants plan for drug price increases anticipated in 2019-2020.

The forecast also offers analysis and insights from our subject matter experts on critical topics such as drug shortages, biosimilars and regulatory changes.

Drug Price Forecast